Light-chain Amyloidosis
📧 Sign up to get email alerts when something new happens for Light-chain Amyloidosis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-06-16FDA Approved: DARZALEX — Supplemental Application (Janssen Biotech, Inc.)
The FDA approved a supplemental application for DARZALEX (daratumumab) submitted by Janssen Biotech, Inc. to modify/expand the approved use.